Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

NutriBand (NTRB) EBITDA (2018 - 2025)

NutriBand (NTRB) has disclosed EBITDA for 8 consecutive years, with -$3.9 million as the latest value for Q4 2025.

  • Quarterly EBITDA fell 171.95% to -$3.9 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$12.9 million through Oct 2025, down 113.11% year-over-year, with the annual reading at -$10.3 million for FY2025, 111.1% down from the prior year.
  • EBITDA hit -$3.9 million in Q4 2025 for NutriBand, down from -$2.0 million in the prior quarter.
  • In the past five years, EBITDA ranged from a high of -$315057.0 in Q2 2021 to a low of -$5.6 million in Q1 2025.
  • Historically, EBITDA has averaged -$1.8 million across 5 years, with a median of -$1.4 million in 2024.
  • Biggest five-year swings in EBITDA: tumbled 3592.41% in 2021 and later surged 57.65% in 2023.
  • Year by year, EBITDA stood at -$1.6 million in 2021, then skyrocketed by 31.58% to -$1.1 million in 2022, then plummeted by 60.25% to -$1.7 million in 2023, then rose by 17.21% to -$1.4 million in 2024, then plummeted by 171.95% to -$3.9 million in 2025.
  • Business Quant data shows EBITDA for NTRB at -$3.9 million in Q4 2025, -$2.0 million in Q3 2025, and -$1.4 million in Q2 2025.